Advisor Partners Ii, LLC Vertex Pharmaceuticals Inc Transaction History
Advisor Partners Ii, LLC
- $2.47 Billion
- Q3 2023
A detailed history of Advisor Partners Ii, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Advisor Partners Ii, LLC holds 15,732 shares of VRTX stock, worth $6.34 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
15,732
Previous 15,768
0.23%
Holding current value
$6.34 Million
Previous $5.55 Million
1.41%
% of portfolio
0.22%
Previous 0.26%
Shares
5 transactions
Others Institutions Holding VRTX
# of Institutions
1,809Shares Held
239MCall Options Held
1.95MPut Options Held
1.14M-
Capital World Investors Los Angeles, CA28.7MShares$11.6 Billion1.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA24MShares$9.67 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.6 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.1MShares$6.5 Billion1.5% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.75 Billion0.2% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $104B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...